1.
Archives of Internal Medicine
; 168(1): 94-102, jan 2008.
Article
de Anglais
| Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP
| ID: biblio-1059822
RÉSUMÉ
Despite widespread heparin use in clinical practice, the associated development of thrombocitopenia is an underrecognized and undertreaded complication. Methods:We analized data from consective hospitalized patients treated with heparin (unfractionated or low molecular weight) for four days or longer to determine the incidence, predictors, prognostic significance, and management of thrombocitopenia, defined as a platelet count less than 150x10/L, reduction in platelet count of 50% or more from teh admission level, or both...